Thalassemia (Transfusion Delendent)
1 clinical trials · Condition
◉ Watch Thalassemia (Transfusion Delendent)
| Record | Firm | Date |
|---|---|---|
| Effect of Deferasirox on Endocrine Complications in Subjects With Transfusion Dependent Thalassemia (NCT02069886) | Novartis Pharmaceuticals | 2014-12-01 |
Track Thalassemia (Transfusion Delendent) automatically
Every clearance here is in the API, with alerts when new ones post.